Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Treatment withdrawal · people with drug‐resistant focal epilepsy

It is very uncertain whether carisbamate changes treatment withdrawal for any reason compared with placebo (very low certainty).

1 finding from 1 review

Carisbamate add‐on therapy for drug‐resistant focal epilepsy 2021 · Cochrane Headline outcomes only
RR 1.32 [0.82, 2.12]
4 studies · 2211 participants
Very low

Withdrawals due to adverse events · people with drug‐resistant focal epilepsy

It is very uncertain whether carisbamate changes treatment withdrawal due to adverse events compared with placebo (very low certainty).

1 finding from 1 review

Carisbamate add‐on therapy for drug‐resistant focal epilepsy 2021 · Cochrane Headline outcomes only
RR 1.8 [0.78, 4.17]
4 studies · 2211 participants
Very low